Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerome Ritz

Showing results (61-70 of 315) with videos related to

Pageof 32
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 5, 2019
Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402)Mahasweta Gooptu, Haesook T Kim, Alan Howard, et al.
Blood|June 10, 2006
SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic miceYupo Ma, Wei Cui, Jianchang Yang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 5, 2002
Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusionRobert J Soiffer, Edwin P Alyea, Ephraim Hochberg, et al.
Cancer Research|October 3, 2002
CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cellsXiao-Feng Yang, Catherine J Wu, Linyun Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
High levels of B-cell activating factor in patients with active chronic graft-versus-host diseaseStefanie Sarantopoulos, Kristen E Stevenson, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 11, 2009
Combined CD4+ donor lymphocyte infusion and low-dose recombinant IL-2 expand FOXP3+ regulatory T cells following allogeneic hematopoietic stem cell transplantationEmmanuel Zorn, Mehrdad Mohseni, Haesook Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 28, 2006
Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndromeEdwin P Alyea, Haesook T Kim, Vincent Ho, et al.
Experimental Hematology|October 11, 2003
Molecular assessment of erythroid lineage chimerism following nonmyeloablative allogeneic stem cell transplantationCatherine J Wu, Ephraim P Hochberg, Shelby A Rogers, et al.
Plos One|July 16, 2015
IL-7 and SCF Levels Inversely Correlate with T Cell Reconstitution and Clinical Outcomes after Cord Blood Transplantation in AdultsIoannis Politikos, Haesook T Kim, Sarah Nikiforow, et al.
Leukemia & Lymphoma|July 22, 2024
A phase I trial of vaccination with lethally irradiated lymphoma cells admixed with granulocyte-macrophage colony-stimulating factor secreting K562 cells for the treatment of follicular lymphomaEric Jacobsen, Ashley Plant, Robert Redd, et al.
Pageof 32

Showing results (61-70 of 315) with videos related to

Sort By:
Pageof 32
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 5, 2019
Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402)Mahasweta Gooptu, Haesook T Kim, Alan Howard, et al.
Blood|June 10, 2006
SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic miceYupo Ma, Wei Cui, Jianchang Yang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 5, 2002
Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusionRobert J Soiffer, Edwin P Alyea, Ephraim Hochberg, et al.
Cancer Research|October 3, 2002
CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cellsXiao-Feng Yang, Catherine J Wu, Linyun Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
High levels of B-cell activating factor in patients with active chronic graft-versus-host diseaseStefanie Sarantopoulos, Kristen E Stevenson, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 11, 2009
Combined CD4+ donor lymphocyte infusion and low-dose recombinant IL-2 expand FOXP3+ regulatory T cells following allogeneic hematopoietic stem cell transplantationEmmanuel Zorn, Mehrdad Mohseni, Haesook Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 28, 2006
Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndromeEdwin P Alyea, Haesook T Kim, Vincent Ho, et al.
Experimental Hematology|October 11, 2003
Molecular assessment of erythroid lineage chimerism following nonmyeloablative allogeneic stem cell transplantationCatherine J Wu, Ephraim P Hochberg, Shelby A Rogers, et al.
Plos One|July 16, 2015
IL-7 and SCF Levels Inversely Correlate with T Cell Reconstitution and Clinical Outcomes after Cord Blood Transplantation in AdultsIoannis Politikos, Haesook T Kim, Sarah Nikiforow, et al.
Leukemia & Lymphoma|July 22, 2024
A phase I trial of vaccination with lethally irradiated lymphoma cells admixed with granulocyte-macrophage colony-stimulating factor secreting K562 cells for the treatment of follicular lymphomaEric Jacobsen, Ashley Plant, Robert Redd, et al.
Pageof 32